ClinicalTrials.Veeva

Menu

Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Selenium

Treatments

Drug: Selenium

Study type

Interventional

Funder types

Other

Identifiers

NCT04942769
2021-310

Details and patient eligibility

About

To evaluate the effects of exogenous selenium supplementation on autoimmune thyroiditis.

Full description

In patients with autoimmune thyroiditis, investigators compared changes in thyroid function, anti-thyroid peroxidase antibody, anti-thyroglobulin antibody, thyroid magnetic resonance T1-mapping values and metabolic indicatorsfrom baseline to the end of treatment (12 weeks)

Enrollment

30 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men or women between the ages of 18 and 75
  • Clinical diagnosis of autoimmune thyroiditis, serum TPOAb and TGAB positive
  • Thyroid function is normal, and no drugs affecting thyroid function such as Umetole and Serge have been used

Exclusion criteria

  • The contraindications indicated in the Chinese instructions of the drug
  • Hypothyroidism, hyperthyroidism
  • Liver function impairment
  • Renal function impairment
  • Claustrophobia
  • Mental disorders

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

selenium
Experimental group
Description:
selenium was administered to patients with autoimmune thyroiditis
Treatment:
Drug: Selenium

Trial contacts and locations

1

Loading...

Central trial contact

Xiaomeng Sun; Jia Liu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems